Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
2(100.0%)
2Total
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06952712Phase 3Not Yet Recruiting

Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women

Role: lead

NCT06339749Recruiting

Pregnancy Outcomes in Normotensive VS stage1 Hypertension: a Prospective Observational Study

Role: lead

NCT06111079Phase 3Recruiting

Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

Role: lead

All 3 trials loaded